An enterovirus vaccine developed in Taiwan has proved highly successful in the animal testing stage and is set to proceed to human clinical trials, a researcher at the National Health Research Institutes (NHRI) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan chip sector urged to reduce reliance on China's rare earths
12/04/2025 10:25 PM - Society
Taiwan launches US$767 million program to boost 'medical resilience'
12/04/2025 09:57 PM - Business
Taiwan, Japan sign two deals on customs cooperation, digital trade
12/04/2025 09:18 PM - Cross-Strait
- Politics